The growing global immunodiagnostic market

Screening and diagnosing diseases at earlier stages save lives and decrease costs in health care.  This ongoing evolution has resulted in a growing immunodiagnostic market. Today the global market of antibody-based diagnostics has reached the large figure of $ 11.2 billion. Moreover, recent published sales results from Roche confirm this increasing global immunodiagnostic market, where they show that they are experiencing a yearly growth of 12%.

Capra Science Antibodies manufactures antibodies for immunodiagnostic companies within health care, as well as the veterinary market.